Ascletis Announces Oral and Poster Presentations on ASC47, an Adipose-Targeted, Muscle-Preserving Weight Loss Drug Candidate for Obesity at the 32nd European Congress on Obesity ...Middle East

HONG KONG, May 6, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces oral and poster presentations on preliminary studies of ASC47, an adipose-targeted, muscle-preserving weight loss drug candidate for obesity, will be presented at the 32nd European Congress On...

Read More Details
Finally We wish PressBee provided you with enough information of ( Ascletis Announces Oral and Poster Presentations on ASC47, an Adipose-Targeted, Muscle-Preserving Weight Loss Drug Candidate for Obesity at the 32nd European Congress on Obesity )

Also on site :

• Halle Berry risks wardrobe malfunction on Met Gala 2025 red carpet with strategically placed stripes
• Maluma Honors Pachuco Culture in Zoot Suit at Met Gala 2025
• Zendaya Suits Up for Her Most Unexpected Look to Date at 2025 Met Gala